Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000147501 | SCV000194938 | benign | not specified | 2017-11-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000147501 | SCV000518781 | benign | not specified | 2016-10-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000677069 | SCV001106726 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000677069 | SCV001962424 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | SLC25A1: BP4, BP7, BS2 |
Prevention |
RCV003917455 | SCV004731157 | likely benign | SLC25A1-related condition | 2020-02-21 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Mayo Clinic Laboratories, |
RCV000677069 | SCV000802905 | likely benign | not provided | 2016-02-19 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000147501 | SCV002033978 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000677069 | SCV002038480 | likely benign | not provided | no assertion criteria provided | clinical testing |